Fucoidan from Undaria pinnatifida has anti-diabetic effects by stimulation of glucose uptake and reduction of basal lipolysis in 3T3-L1 adipocytes
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Fucoidan, a sulfated polysaccharide derived from brown seaweeds, has been shown to reduce blood glucose levels and improve insulin sensitivity in mice. We investigated the effects of fucoidan on lipid accumulation, lipolysis, and glucose uptake in 3T3-L1 cells to test the hypothesis that fucoidan exerts an anti-diabetic function by acting directly on adipocytes. The 3T3-L1 cells were treated with 10, 50, 100, and 200 μg/mL of fucoidan from Undaria pinnatifida. Oil Red O staining and AdipoRed assay were used to determine lipid accumulation during adipocyte differentiation. Fucoidan was shown to reduce lipid accumulation and glycerol-3-phosphate dehydrogenase (GPDH) activity in a dose-dependent manner (P < .01). The expression of peroxisome proliferator-activated receptor γ (PPARγ), a major transcription factor associated with adipocyte differentiation, was also suppressed upon treatment with fucoidan. Treatment with fucoidan stimulated glucose uptake in normal adipocytes and restored insulin-stimulated glucose uptake in obesity-induced insulin resistant adipocytes, which were made by incubating hypertrophied 3T3-L1 cells with the conditioned media of RAW 264.7 macrophages (RAW-CM) (P < .01). In the presence of RAW-CM, fucoidan enhanced epinephrine-stimulated lipolysis but reduced basal lipolysis, as determined by non-esterified fatty acid into the culture medium (P < .001). These results suggest that fucoidan may have anti-diabetic effects by improving insulin-stimulated glucose uptake and inhibiting basal lipolysis in adipocytes without inducing adipogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Fucoidan: Structure and bioactivity
Li, B., Lu, F., Wei, X., & Zhao, R. (2008) · Molecules · doi:10.3390/molecules13081671 · Cited by 1,383
Cho, M. L., Lee, B.-Y., & You, S. G. (2010) · Molecules · doi:10.3390/molecules16010291 · Cited by 155
A quantitative method to detect fucoidan in human plasma using a novel antibody
Irhimeh, M. R., Fitton, J. H., Lowenthal, R. M., & Kongtawelert, P. (2005) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2005.27.10.948919 · Cited by 121
Lin, H.-T., Tsou, Y.-C., Chen, Y.-T., Lu, W.-J., & Hwang, P.-A. (2017) · Marine Drugs · doi:10.3390/md15040113 · Cited by 114
Kim, K.-J., & Lee, B.-Y. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.04.003 · Cited by 97
Cited by
Fucoidan in pharmaceutical formulations: A comprehensive review for smart drug delivery systems
Haggag, Y., Abd Elrahman, A., Ulber, R., & Zayed, A. (2023) · Marine Drugs · doi:10.3390/md21020112 · Cited by 126
“Other reported mech nisms inclu e the role of fucoidan in modulating oxidative stress and gut microbiota [13,14].”
BackgroundAleissa, M. S., Alkahtani, S., Abd Eldaim, M. A., Ahmed, A. M., Bungău, S. G., Almutairi, B., Bin-Jumah, M., AlKahtane, A. A., Alyousif, M. S., & Abdel-Daim, M. M. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9316751 · Cited by 88
Oral Fucoidan Improves Muscle Size and Strength in Mice
McBean, S. E., Church, J. E., Thompson, B. K., Taylor, C. J., Fitton, J. H., Stringer, D. N., Karpiniec, S. S., Park, A. Y., & Poel, C. (2021) · Physiological Reports · doi:10.14814/phy2.14730 · Cited by 19
“Previous studies have already demonstrated that fucoidan can increase insulin-stimulated glucose uptake (Sim et al., 2019) and prevent β-cell dysfunction (Yu et al., 2017).”
Background
Metadata
- Authors
- Sim, S.-Y., Shin, Y.-E., & Kim, H.-K.
- Venue
- Nutrition Research
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 65
- Pages
- 54-62
- ISSN
- 0271-5317 (ISSN-L)
- OpenAlex
- W2915494515
- Cited by
- 71
- References
- 7
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.